Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Insulin for Diabetic Wound Healing
NCT01295177Phase 2Completed
- Sponsor
- Universidade Estadual de Campinas
- Start
- Jan 2004
- Primary completion
- Aug 2007
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised, double-blind trial of Generex Oral-lyn in diabetic foot ulcer (DFU) (2 arms), sponsored by Universidade Estadual de Campinas. Primary endpoint: Percentage of Wound healing closing at 7 days. Started Jan 2004; status: completed.
02
Drugs
Generex Oral-lyn
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT01295177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01295177.